Inventor · disambiguated record
Emanuele Perola
Also filed as: PEROLA EMANUELE
42 granted patents·18 pending applications·373 citations·filing 2002–2024
98Inventor score
Top patents by PatentIndex Score
60 records- 0196US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0296US9394302B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·19 cites·6 claims
- 0396US9051319B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·24 cites·2 claims
- 0495US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 0594US11534441B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 27, 2022·3 cites·25 claims
- 0694US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 0794US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 0894US8871774B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Oct 28, 2014·18 cites·29 claims
- 0993US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 1093US8067606B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Nov 29, 2011·14 cites·24 claims
- 1192US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 1292US9908878B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Mar 6, 2018·8 cites·16 claims
- 1392US7964624B1Inhibitors of serine proteasesVERTEX PHARMA·Filed 2007·Granted Jun 21, 2011·21 cites·27 claims
- 1491US8193352B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2009·Granted Jun 5, 2012·11 cites·18 claims
- 1590US12042495B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jul 23, 2024·1 cites·18 claims
- 1689US11932648B2CDK2 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Mar 19, 2024·1 cites·18 claims
- 1789US8034832B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2009·Granted Oct 11, 2011·13 cites·7 claims
- 1889US7582641B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Sep 1, 2009·21 cites·28 claims
- 1988US8188095B2Gyrase inhibitors and uses thereofCHARIFSON PAUL·Filed 2008·Granted May 29, 2012·11 cites·6 claims
- 2088US7618974B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Nov 17, 2009·21 cites·19 claims
- 2187US8404852B2Gyrase inhibitors and uses thereofCHARIFSON PAUL S·Filed 2011·Granted Mar 26, 2013·10 cites·13 claims
- 2287US7985762B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2006·Granted Jul 26, 2011·8 cites·54 claims
- 2387US7569591B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Aug 4, 2009·27 cites·2 claims
- 2487US7495014B2Gyrase inhibitors and uses thereofVERTEX PHARMA·Filed 2004·Granted Feb 24, 2009·25 cites·24 claims
- 2584US8481551B2Gyrase and topoisomerase IV inhibitorsLE TIRAN ARNAUD·Filed 2012·Granted Jul 9, 2013·13 cites·24 claims
- 2682US9937192B2Combination therapy to treat mycobacterium diseasesSPERO TRINEM INC·Filed 2017·Granted Apr 10, 2018·2 cites·16 claims
- 2780US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 2878US8969359B2Gyrase and topoisomerase IV inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·3 cites·25 claims
- 2978US8440706B2Inhibitors of serine proteasesCOTTRELL KEVIN M·Filed 2011·Granted May 14, 2013·3 cites·12 claims
- 3077US12448379B2Wild type kit inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Granted Oct 21, 2025·0 cites·33 claims
- 3177US10118904B2Triazoles for the treatment of Demyelinating DiseasesVERTEX PHARMA·Filed 2016·Granted Nov 6, 2018·3 cites·34 claims
- 3273US7919520B2Inhibitors of taceVERTEX PHARMA·Filed 2008·Granted Apr 5, 2011·1 cites·3 claims
- 3372US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 3469US8372873B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2011·Granted Feb 12, 2013·1 cites·23 claims
- 3568US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 3667US2021040092A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2020·Application pending·0 cites
- 3766US7485664B2Inhibitors of TACEVERTEX PHARMA·Filed 2003·Granted Feb 3, 2009·2 cites·22 claims
- 3865US10875855B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·16 claims
- 3963US8202889B2Inhibitors of bacterial IMPDHCHARIFSON PAUL·Filed 2006·Granted Jun 19, 2012·0 cites·1 claims
- 4062US7345048B2Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitorsPLIVA D D·Filed 2002·Granted Mar 18, 2008·4 cites·22 claims
- 4162US2025236608A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 4261US12202844B2MAP4K1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Jan 21, 2025·0 cites·30 claims
- 4360US2025074895A1Cdk2 inhibitors and methods of making and using sameBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4460US2024336630A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4560US2025270190A1Kit inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 4660US2024382483A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4759US9572809B2Combination therapy to treat Mycobacterium diseasesSPERO TRINEM INC·Filed 2013·Granted Feb 21, 2017·0 cites·28 claims
- 4859US2024199648A1Map4k1 inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4958US2024299387A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 5058US2024308981A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Emanuele Perola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →